Akita Biosciences Launches to Pioneer Novel Intranasal Therapies
/PRNewswire/ -- Akita Biosciences, a biotechnology company focused on consumer health, is launching today with a mission to bring novel therapies to market....
Stay updated with breaking news from Associate Bioengineer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Akita Biosciences, a biotechnology company focused on consumer health, is launching today with a mission to bring novel therapies to market....
A new technique takes bioprinting -; in which an ink of cells is printed, layer by layer, to form a structure -; to a whole new, and icy level. Investigators from the Zhang lab at Brigham and Women's Hospital have developed a technology that they term "cryobioprinting," a method that uses a bioink embedded with cells to print frozen, complex structures that can be easily stored for later use.
A team of researchers has designed a 3D "lung-on-a-chip" model that replicates human alveolar lung tissue to test new therapies for Covid-19 and other lung conditions.The model will help study how Covid viral particles travel through ...
New Nanoparticle Platform Could Help Treat Various Neurological Disorders Written by AZoNanoJan 4 2021 Over the last few decades, scientists have established the biological pathways that cause neurodegenerative diseases and have created potential molecular agents to target these pathways. Yet, there has been a delay in translating these discoveries into clinically approved treatments, partially due to the challenges faced by researchers in delivering therapeutics into the brain through the blood-brain barrier (BBB). To enable the successful delivery of therapeutic agents into the brain, a gro...